{"symbol":"JNJ","provider":"yahoo-finance","fetchedAt":"2025-12-26T10:19:31.856Z","asOfDate":"2025-12-26","articles":[{"id":"1cc2f975-ad6b-348c-b50b-60e579b6245a","title":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","url":"https://finance.yahoo.com/m/1cc2f975-ad6b-348c-b50b-60e579b6245a/dogs-of-the-dow-beat-the.html","publisher":"24/7 Wall St.","publishedAt":"2025-12-25T14:50:50.000Z","relatedTickers":["T","TMUS","VZ"],"mainIdea":"Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026","summary":"24/7 Wall St.: Dogs of the Dow Beat the Market in 2025 — Here’s the Smarter 4-Stock Play for 2026. Related tickers mentioned: T, TMUS, VZ."},{"id":"a89a21b0-4158-368a-8375-a69745a3275a","title":"PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth","url":"https://finance.yahoo.com/news/pfes-oncology-obesity-pipeline-position-162000310.html","publisher":"Zacks","publishedAt":"2025-12-24T16:20:00.000Z","relatedTickers":["MRK","PFE"],"mainIdea":"PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth","summary":"Zacks: PFE's Oncology & Obesity Pipeline Position It for Post-LOE Growth. Pfizer faces revenue pressure from 2026-2030 LOEs but is betting on a strengthened oncology and obesity pipeline to fuel sustainable post-LOE growth. Related tickers mentioned: MRK, PFE."},{"id":"df617187-3df3-3fce-82ae-4f9ab511f28e","title":"The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley","url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-invesco-144900649.html","publisher":"Zacks","publishedAt":"2025-12-24T14:49:00.000Z","relatedTickers":["BG","IVZ","MS","MS-PQ","NI","^GSPC"],"mainIdea":"The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley","summary":"Zacks: The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley. Invesco leads Zack' list of five high-yield S&P 500 stocks, highlighting dividend strength and steady income potential for 2026. Related tickers mentioned: BG, IVZ, MS, MS-PQ, NI, ^GSPC."}]}
